78 related articles for article (PubMed ID: 22047406)
1. YY1 overexpression is associated with poor prognosis and metastasis-free survival in patients suffering osteosarcoma.
de Nigris F; Zanella L; Cacciatore F; De Chiara A; Fazioli F; Chiappetta G; Apice G; Infante T; Monaco M; Rossiello R; De Rosa G; Alberghini M; Napoli C
BMC Cancer; 2011 Nov; 11():472. PubMed ID: 22047406
[TBL] [Abstract][Full Text] [Related]
2. Massage manipulation and progression of osteosarcoma, does it really correlate: a combination of prospective and retrospective cohort study.
Karda IWAM; Wan Ismail WF; Kamal AF
Sci Rep; 2023 Oct; 13(1):18541. PubMed ID: 37899365
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PD-L1 Expression by YY1 in Cancer: Therapeutic Efficacy of Targeting YY1.
Dillen A; Bui I; Jung M; Agioti S; Zaravinos A; Bonavida B
Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539569
[TBL] [Abstract][Full Text] [Related]
4. Metformin alleviates adriamycin resistance of osteosarcoma by declining YY1 to inhibit MDR1 transcriptional activity.
Wu B; Li P; Qiu E; Chen J
BMC Pharmacol Toxicol; 2023 Oct; 24(1):50. PubMed ID: 37828612
[TBL] [Abstract][Full Text] [Related]
5. Targeting Transcription Factor YY1 for Cancer Treatment: Current Strategies and Future Directions.
Hosea R; Hillary S; Wu S; Kasim V
Cancers (Basel); 2023 Jul; 15(13):. PubMed ID: 37444616
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the roles and clinical potential of YY1 in the tumor microenvironment.
Li M; Wei J; Xue C; Zhou X; Chen S; Zheng L; Duan Y; Deng H; Xiong W; Tang F; Li G; Zhou M
Front Oncol; 2023; 13():1122110. PubMed ID: 37081988
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of a Prognostic Model for Overall Survival in Patients with Primary Pelvis and Spine Osteosarcoma: A Population-Based Study and External Validation.
Wang D; Liu F; Li B; Xu J; Gong H; Yang M; Wan W; Jiao J; Liu Y; Xiao J
J Clin Med; 2023 Mar; 12(7):. PubMed ID: 37048606
[TBL] [Abstract][Full Text] [Related]
8. Super-Enhancers, Phase-Separated Condensates, and 3D Genome Organization in Cancer.
Tang SC; Vijayakumar U; Zhang Y; Fullwood MJ
Cancers (Basel); 2022 Jun; 14(12):. PubMed ID: 35740532
[TBL] [Abstract][Full Text] [Related]
9. lncRNA HCG11 suppresses human osteosarcoma growth through upregulating p27 Kip1.
Gu J; Dai B; Shi X; He Z; Xu Y; Meng X; Zhu J
Aging (Albany NY); 2021 Sep; 13(17):21743-21757. PubMed ID: 34518440
[TBL] [Abstract][Full Text] [Related]
10. YY1 Silencing Induces 5-Fluorouracil-Resistance and
Vivarelli S; Falzone L; Candido S; Bonavida B; Libra M
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445183
[TBL] [Abstract][Full Text] [Related]
11. Lysosome purinergic receptor P2X4 regulates neoangiogenesis induced by microvesicles from sarcoma patients.
Palinski W; Monti M; Camerlingo R; Iacobucci I; Bocella S; Pinto F; Iannuzzi C; Mansueto G; Pignatiello S; Fazioli F; Gallo M; Marra L; Cozzolino F; De Chiara A; Pucci P; Bilancio A; de Nigris F
Cell Death Dis; 2021 Aug; 12(9):797. PubMed ID: 34404763
[TBL] [Abstract][Full Text] [Related]
12. Clinical epigenetics settings for cancer and cardiovascular diseases: real-life applications of network medicine at the bedside.
Sarno F; Benincasa G; List M; Barabasi AL; Baumbach J; Ciardiello F; Filetti S; Glass K; Loscalzo J; Marchese C; Maron BA; Paci P; Parini P; Petrillo E; Silverman EK; Verrienti A; Altucci L; Napoli C;
Clin Epigenetics; 2021 Mar; 13(1):66. PubMed ID: 33785068
[TBL] [Abstract][Full Text] [Related]
13. TNK2-AS1 upregulated by YY1 boosts the course of osteosarcoma through targeting miR-4319/WDR1.
Yao W; Yan Q; Du X; Hou J
Cancer Sci; 2021 Feb; 112(2):893-905. PubMed ID: 33164271
[TBL] [Abstract][Full Text] [Related]
14. The biological implications of Yin Yang 1 in the hallmarks of cancer.
Meliala ITS; Hosea R; Kasim V; Wu S
Theranostics; 2020; 10(9):4183-4200. PubMed ID: 32226547
[TBL] [Abstract][Full Text] [Related]
15. Hybrid
Schiano C; Franzese M; Pane K; Garbino N; Soricelli A; Salvatore M; de Nigris F; Napoli C
Cancers (Basel); 2019 Sep; 11(10):. PubMed ID: 31561604
[TBL] [Abstract][Full Text] [Related]
16. Genetic Variant of
Xu L; Ni J; Wang Y; Dong Y; Wang S
Technol Cancer Res Treat; 2019 Jan; 18():1533033819874802. PubMed ID: 31522615
[TBL] [Abstract][Full Text] [Related]
17. Blocking of YY1 reduce neutrophil infiltration by inhibiting IL-8 production via the PI3K-Akt-mTOR signaling pathway in rheumatoid arthritis.
Lin J; He Y; Wang B; Xun Z; Chen S; Zeng Z; Ou Q
Clin Exp Immunol; 2019 Feb; 195(2):226-236. PubMed ID: 30229869
[TBL] [Abstract][Full Text] [Related]
18. Post-surgery fluids promote transition of cancer stem cell-to-endothelial and AKT/mTOR activity, contributing to relapse of giant cell tumors of bone.
Fazioli F; Colella G; Miceli R; Di Salvatore MG; Gallo M; Boccella S; De Chiara A; Ruosi C; de Nigris F
Oncotarget; 2017 Oct; 8(49):85040-85053. PubMed ID: 29156702
[TBL] [Abstract][Full Text] [Related]
19. miRNA-584-3p inhibits gastric cancer progression by repressing Yin Yang 1- facilitated MMP-14 expression.
Zheng L; Chen Y; Ye L; Jiao W; Song H; Mei H; Li D; Yang F; Li H; Huang K; Tong Q
Sci Rep; 2017 Aug; 7(1):8967. PubMed ID: 28827574
[TBL] [Abstract][Full Text] [Related]
20. New Cross-Talk Layer between Ultraconserved Non-Coding RNAs, MicroRNAs and Polycomb Protein YY1 in Bladder Cancer.
Terreri S; Durso M; Colonna V; Romanelli A; Terracciano D; Ferro M; Perdonà S; Castaldo L; Febbraio F; de Nigris F; Cimmino A
Genes (Basel); 2016 Dec; 7(12):. PubMed ID: 27983635
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
